Lucie Essayan

Lucie Essayan

Auto-generated profile, based on publicly available information

Lucie Essayan

3d.FAB - Université Lyon1

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2023 in Bioprinting
Verified
Journal Article
Closed access
LCLaura Chastagnier
Laura Chastagnier
NENaima El-Kholti
Naima El-Kholti
LELucie Essayan
Lucie Essayan
CTCéline Thomann
Céline Thomann
ECEdwin Courtial
Edwin Courtial
EPEmma Petiot
Emma Petiot

13 July 2022 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Closed access
SPSarah Pragnere
Sarah Pragnere
NKNaima El Kholti
Naima El Kholti
LGLeslie Gudimard
Leslie Gudimard
LELucie Essayan
Lucie Essayan
Christophe A. MarquetteChristophe A. Marquette
Christophe A. Marquette
CPCyril Pailler-Mattei
Cyril Pailler-Mattei

2 July 2024 in Bioprinting
Verified
Journal Article
Open access
Christophe A. MarquetteChristophe A. Marquette
Christophe A. Marquette
LCLaura Chastagnier
Laura Chastagnier
BSBenjamin Da Sousa
Benjamin Da Sousa
CCCarlos Chocarro-Wrona
Carlos Chocarro-Wrona
ECEdwin Courtial
Edwin Courtial
SPSarah Pragnère
Sarah Pragnère

4 December 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
SGSandrine Vadon-Le Goff
Sandrine Vadon-Le Goff
ATAgnès Tessier
Agnès Tessier
MNManon Napoli
Manon Napoli
CDCindy Dieryckx
Cindy Dieryckx
JBJulien Bauer
Julien Bauer
CMCatherine Moali
Catherine Moali
BMP-1/tolloid-like proteinases (BTPs) are major players in tissue morphogenesis, growth and repair. They act by promoting the deposition of structural extracellular matrix proteins and by controlling the activity of matricellular proteins and TGF-β superfamily growth factors. They have also been implicated in several pathological conditions such as fibrosis, cancer, metabolic disorders and bone diseases. Despite this broad range of pathophysiological functions, the putative existence of a specific endogenous inhibitor capable of controlling their activities could never be confirmed. Here, we show that procollagen C-proteinase enhancer-2 (PCPE-2), a protein previously reported to bind fibrillar collagens and to promote their BTP-dependent maturation, is primarily a potent and specific inhibitor of BTPs which can counteract their proteolytic activities through direct binding. PCPE-2 therefore differs from the cognate PCPE-1 protein and extends the possibilities to fine-tune BTP activities, both in physiological conditions and in therapeutic settings.

25 April 2025 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
ADAlexandre DUFOUR
Alexandre DUFOUR
LELucie Essayan
Lucie Essayan
BKBeomjoon Kim
Beomjoon Kim
VSVincent Salles
Vincent Salles
Christophe A. MarquetteChristophe A. Marquette
Christophe A. Marquette

7 March 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
LCLaura Chastagnier
Laura Chastagnier
NENaima El-Kholti
Naima El-Kholti
LELucie Essayan
Lucie Essayan
CTCéline Thomann
Céline Thomann
ECEdwin Courtial
Edwin Courtial
EPEmma Petiot
Emma Petiot
In recent years, numerous strategies have emerged to answer the growing demand for graftable tissues. Tissue engineering and in-vitro production are one of them. Among all the engineered tissues, skin is one of the most advanced. Nevertheless, biofabrication of graftable and fully functional skin substitutes is still far from being reached. Skin reconstruction, particularly dermis, necessitates cultivation and maturation for several weeks (> 3 weeks) to recover the tissue’s composition and functions, which prevent its transfer to clinical applications. Thus, several strategies, including 3D bioprinting, have been explored to accelerate these productions. In the present study, based on the successful application of 3D bioprinting achieved by our group for skin reconstruction in 21 days, we propose to detail the biological behaviors and maturation phases occurring in the bioprinted skin construct thanks to a descriptive approach transferred from the bioprocess field. The aim is to comprehensively characterize dermis construct maturation phases (cell proliferation and ECM secretion) to master later the interdependent and consecutive mechanisms involved in in-vitro production. Thus, standardized quantitative techniques were deployed to describe 3D bioprinted dermis proliferation and maturation phases. Then, in a second step, various parameters potentially impacting the dermis reconstruction phases were evaluated to challenge our methodology and reveal the biological behavior described (fibroblast proliferation and migration, cell death, ECM remodeling with MMP secretion). The parameters studied concern the bioprinting practice including various printed geometries, bioink formulations and cellular physiology in relation with their nutritional supplementation with selected medium additives.